Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy. (2017)
Attributed to:
Tumour Immunology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2017.01829
PubMed Identifier: 29326711
Publication URI: http://europepmc.org/abstract/MED/29326711
Type: Journal Article/Review
Volume: 8
Parent Publication: Frontiers in immunology
ISSN: 1664-3224